uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 11, 2003

Rexall Agrees to Pay up to $12 million to Users of Misleading Cellulite Supplement

On March 11, 2003, the Federal Trade Commission (FTC) reported that Rexall Sundown, Inc. (Rexall) will pay up to $12 million to resolve FTC charges regarding its marketing of the dietary supplement, "Cellasene," a purported cellulite treatment product. The settlement is contingent on approval by the federal district court in Miami and approval of related settlements in class action lawsuits currently pending against Rexall in California and Florida. If approved, the FTC and class action settlements together will provide up to $12 million in redress for consumers throughout the United States who purchased Cellasene.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at